ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 2456

$379K Total Retail Price of All Prescriptions

Rank: 392 out of 2456

231 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 231 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 8,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
HYDROCHLOROTHIAZIDE 417 391 1 7
METOPROLOL SUCCINATE 407 392 2 13
LISINOPRIL 332 304 3 1
ZOLPIDEM TARTRATE 331 330 4 28
AMLODIPINE BESYLATE 326 312 5 5
SIMVASTATIN 318 283 6 2
OMEPRAZOLE 293 259 7 3
LEVOTHYROXINE SODIUM 282 264 8 4
METOPROLOL TARTRATE 217 198 9 10
PRAVASTATIN SODIUM 210 191 10 15
ATORVASTATIN CALCIUM 206 199 11 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 173 12 41
POTASSIUM CHLORIDE 175 165 13 33
FUROSEMIDE 152 152 14 8
METFORMIN HCL 142 142 15 11
ATENOLOL 131 118 16 6
CITALOPRAM HBR 124 120 17 14
LOSARTAN POTASSIUM 121 121 18 18
GABAPENTIN 117 111 19 16
ACETAMINOPHEN-CODEINE 117 116 S3 19 106
PANTOPRAZOLE SODIUM 115 115 21 37
NIFEDIPINE ER 115 115 21 61
DIOVAN 112 112 23 26
LOSARTAN-HYDROCHLOROTHIAZIDE 105 105 24 117
LIDODERM 94 94 25 58
PROAIR HFA 89 85 26 22
NITROSTAT 89 87 26 169
ALENDRONATE SODIUM 88 88 28 19
GLIMEPIRIDE 87 87 29 74
DIOVAN HCT 87 87 29 139
DONEPEZIL HCL 80 80 31 23
FLUTICASONE PROPIONATE 78 72 32 30
RANITIDINE HCL 75 75 33 31
VERAPAMIL ER 72 72 34 91
ISOSORBIDE MONONITRATE ER 72 72 34 48
NEXIUM 70 70 36 80
WARFARIN SODIUM 66 56 37 9
TAMSULOSIN HCL 66 66 37 32
TRAMADOL HCL 63 61 39 24
MECLIZINE HCL 63 61 39 107
IBUPROFEN 62 38 41 52
ENALAPRIL MALEATE 61 61 42 70
LIPITOR 60 55 43 63
KETOCONAZOLE 56 56 44 221
DOXAZOSIN MESYLATE 55 55 45 71
CRESTOR 54 54 46 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.